Cellebrite DI (CLBT) reported Q1 non-GAAP earnings Wednesday of $0.10 per diluted share, up from $0.08 a year earlier.
Analysts polled by FactSet expected $0.08.
Revenue for the quarter ended March 31 was $107.5 million, compared with $89.6 million a year earlier.
Analysts surveyed by FactSet expected $109.3 million.
The company expects Q2 revenue of $110 million to $116 million. Analysts surveyed by FactSet expect $115.3 million.
Cellebrite said it now expects 2025 revenue of $470 million to $485 million, compared with a prior outlook of $480 million to $490 million. Analysts surveyed by FactSet expect $484.2 million.
The company's shares were down nearly 13% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.